Sign in

CIK 0001746473 · Non-accelerated filer<br>Smaller reporting company

PLIANT THERAPEUTICS, INC.

Sign in to watch
Ticker
PLRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
474272481
Phone
650-481-6770
Business address
331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Planned sale President and CEO sold 52,419 shares at $11.20 ($587,150)
  2. 4 Planned sale Chief Financial Officer sold 20,148 shares at $11.20 ($225,680)
  3. 4 Planned sale Chief Business Officer sold 15,936 shares at $11.20 ($178,501)
  4. 4 Planned sale Chief Medical Officer sold 18,478 shares at $11.20 ($206,974)
  5. 4 Planned sale Chief Human Resource Officer sold 3,740 shares at $11.20 ($41,892)
  6. 4 Planned sale General Counsel & Corp. Sec'y sold 23,500 shares at an average $11.11 ($261,101)
  7. 4 Planned sale Chief Medical Officer sold 12,319 shares at $11.56 ($142,408)
  8. 4 Planned sale Chief Business Officer sold 9,900 shares at $11.56 ($114,444)
  9. 4 Planned sale Chief Financial Officer sold 10,911 shares at $11.56 ($126,131)
  10. 4 Planned sale President and CEO sold 38,710 shares at $11.56 ($447,488)
  11. 4 Planned sale General Counsel & Corp. Sec'y sold 7,656 shares at $11.56 ($88,503)
  12. 4 Grant or award Chief Medical Officer acquired 24,063 shares (grant or award)
  13. 4 Grant or award Chief Business Officer acquired 19,337 shares (grant or award)
  14. 4 Grant or award Chief Financial Officer acquired 21,313 shares (grant or award)
  15. 4 Grant or award President and CEO acquired 75,625 shares (grant or award)
  16. 4 Grant or award General Counsel & Corp. Sec'y acquired 14,954 shares (grant or award)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 3 of 11 · 215 filings